Yayın:
Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks

dc.contributor.authorOnat, Altan
dc.contributor.authorCan, Guenay
dc.contributor.authorAyhan, Erkan
dc.contributor.authorKaya, Zekeriya
dc.contributor.authorHergenc, Guelay
dc.date.accessioned2026-06-27T13:09:37Z
dc.date.issued2009
dc.description.abstractThe issue Of whether or not incident type 2 diabetes mellitus and coronary heart disease (CHD) can be predicted by high-density lipoprotein (HDL) cholesterol in both sexes needs investigation. A representative sample of 3035 middle-aged Turkish adults free of CHD at baseline was studied with this purpose prospectively over a mean of 7.8 years. High-density lipoprotein cholesterol levels were found to be correlated in women positively with plasma fibrinogen and weakly with waist girth and C-reactive protein, and to be not correlated with fasting insulin. High-density lipoprotein cholesterol protected men against future CHID risk (for a 12-mg/dL increment: relative risk = 0.80 [95% confidence interval, 0.69-0.95]) after multivariable adjustment in logistic regression analyses for age, smoking status, physical activity grade, hypertension, abdominal obesity, diabetes, and lipid-lowering drugs. However, men were not protected against risk of diabetes. In women, HDL cholesterol was not associated with risk for CHID, whereas intermediate (40-60 mg/dL) compared with lower HDL cholesterol levels proved protective against risk of diabetes (relative risk = 0.57 [95% confidence interval, 0.36-0.90]) after adjustments that included apolipoprotein A-1 tertiles. Yet higher serum concentrations flailed to yield protection against diabetes. It Was Concluded that HDL particles confer partially lacking protection against cadiometabolic risk among Turks, and this impairment is Modulated by sex. This highly important observation may result from a setting of prevailing chronic subclinical inflammation. (c) 2009 Elsevier Inc. All rights reserved.en
dc.description.sponsorshipTurkish Society of Cardiology
dc.description.sponsorshipAstraZeneca
dc.description.sponsorshipNovartis
dc.description.sponsorshipPfizer
dc.description.sponsorshipSanoltAventis
dc.description.urihttps://doi.org/10.1016/j.metabol.2009.05.004
dc.identifier.doi10.1016/j.metabol.2009.05.004
dc.identifier.eissn1532-8600
dc.identifier.endpage1399
dc.identifier.issn0026-0495
dc.identifier.issue10
dc.identifier.pubmed19570555
dc.identifier.startpage1393
dc.identifier.urihttps://hdl.handle.net/20.500.14981/50553
dc.identifier.volume58
dc.identifier.wos000270327100005
dc.language.isoeng
dc.publisherW B SAUNDERS CO-ELSEVIER INC
dc.relation.ispartofMETABOLISM-CLINICAL AND EXPERIMENTAL
dc.subjectAPOLIPOPROTEIN-A-I
dc.subjectMETABOLIC SYNDROME
dc.subjectCHOLESTEROL LEVELS
dc.subjectSERUM ADIPONECTIN
dc.subjectARTERY-DISEASE
dc.subjectRISK
dc.subjectHDL
dc.subjectOXIDATION
dc.subjectMEN
dc.subjectEndocrinology & Metabolism
dc.titleImpaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar